SETTLEMENT AGREEMENTSettlement Agreement • February 9th, 2005
Contract Type FiledFebruary 9th, 2005This Settlement Agreement (“Agreement”) is entered into between the United States of America, acting through the United States Department of Justice and on behalf of the Food and Drug Administration ("FDA") and its Center for Biologics Evaluation and Research ("CBER"), the National Institutes of Health ("NIH"), the Office of Acquisition Management and Policy of the Department of Health and Human Services (“HHS”), and the HHS Office of Inspector General (“OIG-HHS”)(collectively the “United States”); and James M. Wilson, M.D., Ph.D. ("Dr. Wilson") (hereafter referred to as “the Parties”), through their authorized representatives.